Kernal Biologics
Kernal is creating mRNA 2.0 therapies that work in specific cells
ActiveSummer 2020Artificial Intelligence
About Kernal Biologics
Kernal is creating mRNA 2.0 therapies that work in specific cells
Risk Analysis
Category Risk
9%death rate
Artificial Intelligence: 109 of 1158 startups failed
LOWTeam Size
20people
Median for failed in Artificial Intelligence: 3
Median for active in Artificial Intelligence: 4
External Resources
Read full post-mortem on startups.rip ↗(opens in new tab)Website ↗(opens in new tab)YC Profile ↗(opens in new tab)Report data issue
Post-mortem content hosted on startups.rip — we provide the analytics layer.